Emmanuel Thomas

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. doi The application and mechanism of action of ribavirin in therapy of hepatitis C
    Emmanuel Thomas
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, USA
    Antivir Chem Chemother 23:1-12. 2012
  2. pmc S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders
    Jordan J Feld
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 1800, USA
    Gastroenterology 140:830-9. 2011
  3. pmc HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
    Emmanuel Thomas
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Bethesda, Maryland 20892, USA
    Gastroenterology 142:978-88. 2012
  4. pmc Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
    Emmanuel Thomas
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Hepatology 53:32-41. 2011

Detail Information

Publications4

  1. doi The application and mechanism of action of ribavirin in therapy of hepatitis C
    Emmanuel Thomas
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, USA
    Antivir Chem Chemother 23:1-12. 2012
    ..This review highlights the clinical application and mechanism of action of ribavirin and discusses the future role of ribavirin in treatment of HCV where there are intense research efforts to improve therapy...
  2. pmc S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders
    Jordan J Feld
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 1800, USA
    Gastroenterology 140:830-9. 2011
    ..We assessed the effect of SAMe on the kinetics of the early antiviral response and interferon signaling in nonresponders to previous antiviral therapy and investigated the mechanisms involved...
  3. pmc HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
    Emmanuel Thomas
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Bethesda, Maryland 20892, USA
    Gastroenterology 142:978-88. 2012
    ..Little is known about the function of type III IFNs in intrinsic antiviral innate immunity...
  4. pmc Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
    Emmanuel Thomas
    Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Hepatology 53:32-41. 2011
    ..RNA interference studies excluded the activation of the Toll-like receptor and nuclear factor κB pathways in the action of ribavirin...